Please assess the completion status of the following clinical trial:

Trial Title: RCT of Effects of Device-guided Breathing on Ambulatory BP

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of Hypertension~* Treated with at least one antihypertensive drug~* BP still not controlled (\>135/85 on Ambulatory BP waking average)~Exclusion Criteria:~* Diabetes~* Atrial Fibrillation~* Pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Resperate device used for 8 weeks (Type: EXPERIMENTAL): Participants to use Resperate device to guide breathing for 8 weeks. After the primary 8-week trial, this group is divided into two subgroups to examine 16-week data: one subgroup that stops using the device after 8 weeks, and one asked to continue to use the device for the full 16 weeks.
- Relaxation control device (Type: ACTIVE_COMPARATOR): Participants use modified device to pace breathing in the 13/minute range for daily practice for 8 weeks and no device thereafter
- Usual Care (Type: NO_INTERVENTION): Participants continue their usual medication and other management for their hypertension. All participants (including UC) are given a home BP monitor and asked to take their BP in morning and evening 3 days/week.

Based on this trial design, predict the completion outcome and termination type (if applicable).